Furthermore, the FBG and insulin levels were effectively reduced, and the antioxidant capacity and dyslipidemia were ameliorated in diabetic mice after GD treatment, which had protective effects against diabetes-induced liver damage, and the molecular biology results showed that GD has an obvious effect on reducing FBG by activating the AKT/PI3K signaling pathway. The gene discussed is AKT1; the disease is metabolic syndrome.